Fredun Pharmaceuticals Delivers Robust FY26 Performance; Revenue Jumps 40%, EBITDA Surges 72% and Profit Rises ~60% YoY
May 26, 2026
Mumbai (Maharashtra) [India], May 26: Fredun Pharmaceuticals Limited (BSE - FREDUN | 539730), one of the leading pharmaceutical formulation manufacturing companies in India, diversified across generics, cosmeceuticals, nutraceuticals, mobility, and animal healthcare products, has reported its audited financial results for Q4 FY26 and FY26.
Read More...